benzimidazole has been researched along with Koch's Disease in 10 studies
1H-benzimidazole : The 1H-tautomer of benzimidazole.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Drug resistance in tuberculosis is major threat to human population." | 1.62 | Exploration of potential inhibitors for tuberculosis via structure-based drug design, molecular docking, and molecular dynamics simulation studies. ( Chanda, K; Karuppasamy, R; Rajasekhar, S, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jadhavar, PS | 1 |
| Patel, KI | 1 |
| Dhameliya, TM | 1 |
| Saha, N | 1 |
| Vaja, MD | 1 |
| Krishna, VS | 1 |
| Sriram, D | 2 |
| Chakraborti, AK | 1 |
| Rajasekhar, S | 1 |
| Karuppasamy, R | 1 |
| Chanda, K | 1 |
| Keng Yoon, Y | 1 |
| Ashraf Ali, M | 1 |
| Choon, TS | 1 |
| Ismail, R | 1 |
| Chee Wei, A | 1 |
| Suresh Kumar, R | 1 |
| Osman, H | 1 |
| Beevi, F | 1 |
| Gong, Y | 1 |
| Somersan Karakaya, S | 1 |
| Guo, X | 1 |
| Zheng, P | 1 |
| Gold, B | 1 |
| Ma, Y | 1 |
| Little, D | 1 |
| Roberts, J | 1 |
| Warrier, T | 1 |
| Jiang, X | 1 |
| Pingle, M | 1 |
| Nathan, CF | 1 |
| Liu, G | 1 |
| Knudson, SE | 2 |
| Awasthi, D | 2 |
| Kumar, K | 2 |
| Carreau, A | 1 |
| Goullieux, L | 1 |
| Lagrange, S | 1 |
| Vermet, H | 1 |
| Ojima, I | 2 |
| Slayden, RA | 2 |
| Zhang, HY | 1 |
| Wang, B | 1 |
| Sheng, L | 1 |
| Li, D | 1 |
| Zhang, DF | 1 |
| Lin, ZY | 1 |
| Lu, Y | 1 |
| Li, Y | 1 |
| Huang, HH | 1 |
| Ramprasad, J | 1 |
| Nayak, N | 1 |
| Dalimba, U | 1 |
| Yogeeswari, P | 1 |
| Peethambar, SK | 1 |
| Achur, R | 1 |
| Kumar, HS | 1 |
| Keri, RS | 1 |
| Rajappa, CK | 1 |
| Patil, SA | 1 |
| Nagaraja, BM | 1 |
1 review available for benzimidazole and Koch's Disease
| Article | Year |
|---|---|
Benzimidazole-core as an antimycobacterial agent.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Benzimidazoles; Drug Design; Humans; Mycobact | 2016 |
9 other studies available for benzimidazole and Koch's Disease
| Article | Year |
|---|---|
Benzimidazoquinazolines as new potent anti-TB chemotypes: Design, synthesis, and biological evaluation.
Topics: Animals; Antitubercular Agents; Benzimidazoles; Cell Survival; Dose-Response Relationship, Drug; Dru | 2020 |
Exploration of potential inhibitors for tuberculosis via structure-based drug design, molecular docking, and molecular dynamics simulation studies.
Topics: Antitubercular Agents; Benzimidazoles; Drug Design; Humans; Molecular Docking Simulation; Molecular | 2021 |
Antituberculosis: synthesis and antimycobacterial activity of novel benzimidazole derivatives.
Topics: Antitubercular Agents; Benzimidazoles; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculos | 2013 |
Benzimidazole-based compounds kill Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Benzimidazoles; Cells, Cultured; Drug Design; Humans; Macrophages; Microbial | 2014 |
A trisubstituted benzimidazole cell division inhibitor with efficacy against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Benzimidazoles; Cell Division; Cytoskeletal Prot | 2014 |
In vitro-in vivo activity relationship of substituted benzimidazole cell division inhibitors with activity against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Benzimidazoles; Cell Division; Disease Models, Animal; Drug Combinat | 2014 |
Design and synthesis of novel benzimidazole derivatives as anti-tuberculosis agents.
Topics: Antitubercular Agents; Benzimidazoles; Drug Design; Humans; Structure-Activity Relationship; Tubercu | 2014 |
Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives.
Topics: Animals; Antifungal Agents; Antioxidants; Antitubercular Agents; Benzimidazoles; Cell Survival; Chlo | 2015 |
Finding new ways to prevent disease in food-producing animals.
Topics: Agriculture; Animals; Benzimidazoles; Congresses as Topic; Drug Resistance; Humans; Nanomedicine; Ne | 2016 |